Daiwa Securities Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-204
| Closed | -$6K | – | 1188 |
|
|
2025
Q4 | $6K | Hold |
204
| – | – | ﹤0.01% | 1215 |
|
|
2025
Q3 | $8K | Hold |
204
| – | – | ﹤0.01% | 1166 |
|
|
2025
Q2 | $7K | Hold |
204
| – | – | ﹤0.01% | 1129 |
|
|
2025
Q1 | $6K | Hold |
204
| – | – | ﹤0.01% | 1119 |
|
|
2024
Q4 | $7K | Hold |
204
| – | – | ﹤0.01% | 1139 |
|
|
2024
Q3 | $9K | Hold |
204
| – | – | ﹤0.01% | 1133 |
|
|
2024
Q2 | $9K | Hold |
204
| – | – | ﹤0.01% | 1167 |
|
|
2024
Q1 | $6K | Hold |
204
| – | – | ﹤0.01% | 1191 |
|
|
2023
Q4 | $5K | Hold |
204
| – | – | ﹤0.01% | 1199 |
|
|
2023
Q3 | $5K | Hold |
204
| – | – | ﹤0.01% | 1151 |
|
|
2023
Q2 | $6K | Hold |
204
| – | – | ﹤0.01% | 1164 |
|
|
2023
Q1 | $5K | Hold |
204
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q4 | $6K | Hold |
204
| – | – | ﹤0.01% | 1138 |
|
|
2022
Q3 | $6K | Hold |
204
| – | – | ﹤0.01% | 1151 |
|
|
2022
Q2 | $5K | Buy |
204
+46
| +29% | +$1.04K | ﹤0.01% | 1166 |
|
|
2022
Q1 | $5K | Hold |
158
| – | – | ﹤0.01% | 1169 |
|
|
2021
Q4 | $5K | Sell |
158
-44
| -22% | -$1.77K | ﹤0.01% | 1189 |
|
|
2021
Q3 | $9K | Buy |
202
+80
| +66% | +$3.87K | ﹤0.01% | 1146 |
|
|
2021
Q2 | $7K | Sell |
122
-16
| -12% | -$895 | ﹤0.01% | 1056 |
|
|
2021
Q1 | $7K | Buy |
138
+8
| +6% | +$396 | ﹤0.01% | 1056 |
|
|
2020
Q4 | $6K | Sell |
130
-256
| -66% | -$10.1K | ﹤0.01% | 1041 |
|
|
2020
Q3 | $14K | Hold |
386
| – | – | ﹤0.01% | 1021 |
|
|
2020
Q2 | $14K | Hold |
386
| – | – | ﹤0.01% | 1043 |
|
|
2020
Q1 | $14K | Hold |
386
| – | – | ﹤0.01% | 1030 |
|
|
2019
Q4 | $18K | Buy |
386
+15
| +4% | +$567 | ﹤0.01% | 1019 |
|
|
2019
Q3 | $12K | Hold |
371
| – | – | ﹤0.01% | 1023 |
|
|
2019
Q2 | $19K | Hold |
371
| – | – | ﹤0.01% | 1011 |
|
|
2019
Q1 | $25K | Buy |
371
+57
| +18% | +$3.32K | ﹤0.01% | 981 |
|
|
2018
Q4 | $14K | Hold |
314
| – | – | ﹤0.01% | 983 |
|
|
2018
Q3 | $24K | Hold |
314
| – | – | ﹤0.01% | 991 |
|
|
2018
Q2 | $26K | Hold |
314
| – | – | ﹤0.01% | 1003 |
|
|
2018
Q1 | $26K | Buy |
+314
| New | +$24.3K | ﹤0.01% | 981 |
|
Other funds holding AGIO
FCM
AC
LCM
EAM
Daiwa Securities Group's AGIO Position: Q1 2026 in Review
Daiwa Securities Group sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 204 shares — an estimated $6K sold.
Daiwa Securities Group first reported a position in AGIO in Q1 2018 and held it in 32 quarters. The position peaked at $26K in Q2 2018. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.
- Daiwa Securities Group reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 204 Agios Pharmaceuticals shares in Q1 2026, an estimated $6K.
- Daiwa Securities Group first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's Agios Pharmaceuticals position peaked at $26K in Q2 2018.
- 234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.